https://crstoday.com/news/harrow-completes-transfer-of-ndas-and-launches-branded-ophthalmic-portfolio-in-the-us/2481906/daily0.7https://crstoday.com/news/lighthouse-guild-presents-2023-awards/2481905/daily0.7https://crstoday.com/news/stuart-therapeutics-enters-license-agreement-with-glaukos-for-preclinical-glaucoma-drug-candidate/2481904/daily0.7https://crstoday.com/news/pixium-vision-announces-the-launch-of-a-process-to-find-buyers/2481900/daily0.7https://crstoday.com/news/haag-streit-announces-launch-of-haag-streit-japan/2481899/daily0.7https://crstoday.com/news/lighthouse-guild-to-host-lectures-on-ophthalmic-drug-approvals-technological-innovations-and-advocacy-for-people-with-vision-impairment/2481898/daily0.7https://crstoday.com/news/bausch-lomb-launches-envista-aspire-monofocal-and-toric-iols/2481897/daily0.7https://crstoday.com/news/fda-approves-orasis-pharmaceuticals-presbyopia-eye-drop-qlosi/2481896/daily0.7https://crstoday.com/news/fda-finds-substantive-issues-in-aldeyras-reproxalap-drug-candidate-for-dry-eye-disease/2481895/daily0.7https://crstoday.com/news/splicebio-enters-collaboration-with-spark-therapeutics-to-develop-a-gene-therapy-targeting-an-inherited-retinal-disease/2481894/daily0.7https://crstoday.com/news/optos-unveils-new-retinal-imaging-technology-at-euretina/2481893/daily0.7https://crstoday.com/news/staar-surgical-celebrates-30th-anniversary-of-implantable-collamer-lens-icl/2481892/daily0.7https://crstoday.com/news/baxter-launches-digital-image-capture-capability-of-panoptic-plus-ophthalmoscope/2481891/daily0.7https://crstoday.com/news/tilak-healthcare-raises-eur10-million-to-continue-growing-its-leading-ophthalmological-telemedicine-offering/2481890/daily0.7https://crstoday.com/news/heidelberg-engineering-announces-fda-clearance-of-anterion-platform/2481889/daily0.7https://crstoday.com/news/sight-sciences-presents-phase-1-results-of-the-sahara-trial-comparing-tearcare-to-restasis-for-the-treatment-of-dry-eye-disease/2481888/daily0.7https://crstoday.com/news/aviceda-announces-its-glycomimetic-nanoparticle-candidate-avd-104-demonstrates-clinical-safety-in-the-treatment-of-ga/2481886/daily0.7https://crstoday.com/news/eyesouth-partners-unveils-two-ambulatory-surgery-centers-in-orlando-and-chicago-areas/2481883/daily0.7https://crstoday.com/news/okyo-pharma-announces-filing-of-an-ind-application-for-ok-101-to-treat-neuropathic-corneal-pain/2481882/daily0.7https://crstoday.com/news/haag-streit-announces-winners-of-its-slit-lamp-imaging-competition-2023/2481881/daily0.7https://crstoday.com/news/biotissue-presents-new-data-for-cryopreserved-amniotic-membrane-therapy/2481880/daily0.7https://crstoday.com/news/sightglass-vision-presents-new-data-on-diffusion-optics-technology-myopia-control/2481876/daily0.7https://crstoday.com/news/the-united-nations-marks-world-sight-day-with-first-blurred-photo-exhibition/2481875/daily0.7https://crstoday.com/news/aeye-health-makes-its-one-image-per-eye-diabetic-eye-exam-faster-by-cutting-processing-time-to-under-5-seconds/2481874/daily0.7https://crstoday.com/news/coopervision-to-present-new-scientific-findings-on-presbyopia-correction-and-myopia-management-at-academy-23/2481873/daily0.7https://crstoday.com/news/prevent-blindness-to-host-world-sight-day-congressional-briefing-and-free-vision-screening-on-capitol-hill/2481872/daily0.7https://crstoday.com/news/optometry-giving-sight-sets-500000-fundraising-goal-for-the-2023-world-sight-day-challenge/2481868/daily0.7https://crstoday.com/news/resolving-a-seeming-contradiction-study-advances-understanding-of-visual-recognition-memory/2481866/daily0.7https://crstoday.com/news/bausch-lomb-to-present-new-scientific-data-and-analyses-at-american-academy-of-optometry-annual-meeting/2481865/daily0.7https://crstoday.com/news/lighthouse-guild-announces-2023-awards-for-outstanding-accomplishments-in-vision-science-and-advocacy/2483720/daily0.7https://crstoday.com/news/sight-sciences-announces-new-migs-data-demonstrating-tcor-using-omni-surgical-system-lowers-iop-and-iop-reducing-medications-at-2-years/2481863/daily0.7https://crstoday.com/news/aura-biosciences-expands-leadership-team/2483719/daily0.7https://crstoday.com/news/bausch-lomb-completes-acquisition-of-xiidra/2481861/daily0.7https://crstoday.com/news/viatris-launches-first-national-direct-to-consumer-campaign-for-dry-eye-nasal-spray-tyrvaya/2481860/daily0.7https://crstoday.com/news/zeiss-and-boehringer-ingelheim-partner-to-develop-early-detection-of-eye-diseases-and-prevent-vision-loss/2481859/daily0.7https://crstoday.com/news/harrow-health-changes-corporate-name-to-harrow-inc/2481858/daily0.7https://crstoday.com/news/melt-pharmaceuticals-announces-development-and-license-agreement-with-catalent-for-its-zydis-fast-dissolve-technology/2481857/daily0.7https://crstoday.com/news/neurolens-introduces-n3-vr-based-measurement-and-education-experience/2481854/daily0.7https://crstoday.com/news/oculus-announces-parnership-with-luvo-to-offer-new-ipl-and-rf-devices-for-the-us-ophthalmic-market/2481853/daily0.7https://crstoday.com/news/ocuphire-pharma-and-viatris-receive-fda-approval-of-ryzumvi-for-the-reversal-of-pharmacologically-induced-mydriasis/2481852/daily0.7https://crstoday.com/news/orbis-international-teams-up-with-the-alcon-foundation-and-omega-to-improve-eye-care-in-zambia/2481851/daily0.7https://crstoday.com/news/johnson-johnson-vision-teams-up-with-photographer-and-author-kate-t-parker-for-global-eye-health-inspired-campaign/2483718/daily0.7https://crstoday.com/news/thea-pharma-announces-the-us-launch-of-glaucoma-drug-iyuzeh/2481850/daily0.7https://crstoday.com/news/ppg-flo-optics-announce-supplier-agreement-for-digitally-applied-optical-coatings/2481849/daily0.7https://crstoday.com/news/bostonsight-receives-mmap-grant-to-expand-and-automate-scleral-lens-manufacturing/2481848/daily0.7https://crstoday.com/news/dopavision-completes-enrollment-for-myopiax-1-trial/2481847/daily0.7https://crstoday.com/news/ocucell-announces-funding-from-the-georgia-eye-bank/2481845/daily0.7https://crstoday.com/news/apellis-receives-permanent-j-code-for-ga-drug-syfovre/2481844/daily0.7https://crstoday.com/news/university-of-toronto-researchers-build-online-glaucoma-simulator/2481843/daily0.7https://crstoday.com/news/pixium-vision-complete-reverse-stock-split/2481842/daily0.7https://crstoday.com/news/inventors-of-oct-named-winners-of-2023-lasker-awards/2481841/daily0.7https://crstoday.com/news/zeiss-sets-date-for-annual-zeiss-innovation-week/2481840/daily0.7https://crstoday.com/news/erin-powers-joins-jj-vision-as-vice-president-of-us-sales-and-marketing-for-its-surgical-vision-portfolio/2481838/daily0.7https://crstoday.com/news/sightglass-vision-releases-first-white-paper-on-diffusion-optics-technology/2481837/daily0.7https://crstoday.com/news/sight-sciences-appoints-matt-link-as-chief-commercial-officer/2481835/daily0.7https://crstoday.com/news/altris-receives-fda-clearance-of-altris-ims-platform-for-oct-scan-analysis/2481833/daily0.7https://crstoday.com/news/otsuka-and-shapetx-collaborate-to-develop-aav-gene-therapies-for-ocular-diseases/2481832/daily0.7https://crstoday.com/news/study-finds-role-of-biosynthetic-fatty-acid-pathway-insufficiencies-in-age-related-macular-degeneration/2481831/daily0.7https://crstoday.com/news/novabay-pharmaceuticals-avenova-allograft-is-launched-in-the-united-states/2481830/daily0.7https://crstoday.com/news/neolights-icon-go-with-fluorescein-angiography-capabilities-cleared-by-fda-for-portable-retinal-imaging/2481829/daily0.7https://crstoday.com/news/link-biologics-and-thea-open-innovation-enter-partnership-to-develop-drug-candidate-for-dry-eye-disease/2481828/daily0.7https://crstoday.com/news/business-executive-alex-gorsky-joins-neurotechs-board-as-lead-director/2481827/daily0.7https://crstoday.com/news/bausch-lomb-launches-dry-eye-drug-miebo-in-the-united-states/2481826/daily0.7https://crstoday.com/news/novartis-to-discontinue-development-of-ga-gene-therapy/2481824/daily0.7https://crstoday.com/news/oculis-appoints-rebecca-weil-phd-as-chief-commercial-officer-as-it-enters-pre-commercial-phase/2481823/daily0.7https://crstoday.com/news/novabay-pharmaceuticals-enters-agreement-with-biostem-technologies-to-commercialize-amniotic-tissue-allograft-as-avenova-allograft/2481821/daily0.7https://crstoday.com/news/ace-vision-group-to-present-nine-new-sets-of-scientific-data-focused-on-laser-scleral-microporation-at-the-escrs-annual-meeting/2481820/daily0.7https://crstoday.com/news/alcon-cataract-surgery-with-acrysof-iq-vivity-iols-demonstrates-sustained-high-patient-satisfaction-and-reduced-spectacle-dependence/2481819/daily0.7https://crstoday.com/news/award-winning-actress-dancer-and-director-debbie-allen-joins-prevent-blindness-and-regeneron-to-raise-awareness-of-serious-retinal-diseases/2481818/daily0.7https://crstoday.com/news/eye-care-charity-orbis-announces-new-partnership-with-heidelberg-engineering/2481817/daily0.7https://crstoday.com/news/johnson-johnson-vision-joins-iapb-to-advocate-for-better-eye-health/2483717/daily0.7https://crstoday.com/news/myra-vision-announces-first-in-human-use-of-its-calibreye-glaucoma-drainage-device/2481816/daily0.7https://crstoday.com/news/alcon-to-showcase-new-data-and-innovation-to-support-ophthalmic-surgical-teams-at-escrs/2481815/daily0.7https://crstoday.com/news/ciliatech-presents-preliminary-1-year-study-results-on-treating-open-and-narrow-angle-glaucoma-with-cid/2481814/daily0.7https://crstoday.com/news/bvi-expands-its-presence-in-spain-and-portugal-acquiring-medical-mix/2481813/daily0.7https://crstoday.com/news/bausch-lomb-will-present-new-scientific-data-on-its-surgical-products-and-pipeline-at-escrs/2481812/daily0.7https://crstoday.com/news/digitaloptometrics-to-demonstrate-its-remote-comprehensive-exam-services-with-instant-language-translation-capabilities-at-vision-expo-west/2481811/daily0.7https://crstoday.com/news/sightglass-vision-reports-4-year-clinical-trial-outcomes-for-myopia-control-dot-spectacle-lenses/2481810/daily0.7https://crstoday.com/news/coopervision-to-spotlight-myopia-control-and-management-advocacy-at-escrs/2481809/daily0.7https://crstoday.com/news/rayner-unveils-enhancements-to-digital-platforms-at-escrs-2023/2481808/daily0.7https://crstoday.com/news/eyesouth-partners-affiliates-with-retina-and-vitreous-of-texas/2481807/daily0.7https://crstoday.com/news/amgen-and-horizon-therapeutics-resolve-ftc-lawsuitclearing-path-to-acquisition/2481806/daily0.7https://crstoday.com/news/ocucell-secures-funding-from-the-eye-bank-for-sight-restoration/2481804/daily0.7https://crstoday.com/news/zeiss-to-introduce-new-cataract-and-corneal-refractive-workflow-enhancements-at-escrs-2023/2481803/daily0.7https://crstoday.com/news/johnson-johnson-vision-announces-launch-of-elita-platform-to-correct-myopia-with-new-silk-procedure/2481802/daily0.7https://crstoday.com/news/escrs-releases-the-2022-2023-eurequo-annual-report/2481801/daily0.7https://crstoday.com/news/sydnexis-appoints-nick-ruth-chief-as-commercial-officer/2481799/daily0.7https://crstoday.com/news/apellis-announces-corporate-restructuring-and-workforce-reduction/2481797/daily0.7https://crstoday.com/news/abstract-on-zeta-1-study-of-apx3330-receives-award-at-women-in-ophthalmology-wio-summer-symposium/2481795/daily0.7https://crstoday.com/news/short-term-use-of-immunosuppressants-for-ocular-inflammatory-diseases-not-linked-to-cancer-risk/2481793/daily0.7https://crstoday.com/news/tarsis-launches-demodex-blepharitis-treatment-xdemvy/2481792/daily0.7https://crstoday.com/news/bausch-lomb-provides-update-on-completion-of-xiidra-acquisition/2481791/daily0.7https://crstoday.com/news/fda-warns-consumers-not-to-purchase-or-use-certain-msm-eye-drops-due-to-contamination/2481790/daily0.7https://crstoday.com/news/zeiss-surpasses-8-million-eyes-treated-with-smile-worldwide/2481789/daily0.7https://crstoday.com/news/sciencebased-health-welcomes-new-members-to-its-optometry-clinical-advisory-panel/2481787/daily0.7https://crstoday.com/news/neurophth-announces-first-patient-dosed-in-phase-12-clinical-trial-of-second-gene-therapy/2481786/daily0.7https://crstoday.com/news/amber-ophthalmics-announces-first-patient-enrolled-in-phase-23-trial-evaluating-nexagon-for-the-treatment-of-pced/2481785/daily0.7https://crstoday.com/news/neuro-optometric-rehabilitation-association-names-amy-pruszenski-od-fcovd-as-director-of-medical-education/2483716/daily0.7https://crstoday.com/news/haag-streit-to-present-ophthalmic-skills-training-center-concept-at-escrs-2023/2481783/daily0.7https://crstoday.com/news/nei-scientists-discover-external-protein-network-can-help-stabilize-neural-connections/2481781/daily0.7https://crstoday.com/news/european-medicines-agency-accepts-iveric-bios-marketing-authorization-application-for-avacincaptad-pegol-for-geographic-atrophy/2481780/daily0.7https://crstoday.com/news/lupin-receives-fda-approval-for-generic-ophthalmic-solution/2481778/daily0.7https://crstoday.com/news/bonnie-henderson-md-named-interim-president-and-ceo-of-helpmesee/2481776/daily0.7https://crstoday.com/news/lineage-cell-therapeutics-provides-update-on-opregen/2481775/daily0.7https://crstoday.com/news/rayner-achieves-milestone-implantations-in-clinical-trials-in-china-and-the-us/2481774/daily0.7https://crstoday.com/news/myopia-profile-launches-new-educational-website/2481773/daily0.7https://crstoday.com/news/euclid-vision-issues-statement-on-the-passing-of-co-founder-george-glady/2481771/daily0.7https://crstoday.com/news/penn-medicine-neuroscientists-identify-brain-mechanism-that-drives-focus-despite-distractions/2481770/daily0.7https://crstoday.com/news/prevent-blindness-launches-eyes-on-capitol-hill-online-advocacy-resource/2483715/daily0.7https://crstoday.com/news/oculis-announces-that-ocs-01-first-investigational-eye-drop-for-front-and-back-of-the-eye-met-primary-endpoints-in-phase-3-optimize-trial/2481769/daily0.7https://crstoday.com/news/escrs-launches-new-clinical-research-award-call-focusing-on-presbyopic-iols-in-post-refractive-cataract-patients/2481768/daily0.7https://crstoday.com/news/haag-streit-to-host-eyestar-900-pearls-of-cataract-refractive-surgery-with-swept-source-oct-satellite-symposium/2481767/daily0.7https://crstoday.com/news/laboratoires-thea-acquires-proqr-therapeutics-sepofarsen-and-ultevursen/2481765/daily0.7https://crstoday.com/news/oculis-ocs-01-eye-drops-studied-in-leopard-trial-to-treat-cystoid-macular-edema/2481763/daily0.7https://crstoday.com/news/johnson-johnson-visions-acuvue-abiliti-brand-launches-back-to-school-campaign-to-address-myopia/2481762/daily0.7https://crstoday.com/news/bausch-lomb-solidifies-leadership-team/2481761/daily0.7https://crstoday.com/news/glaucoma-treatment-research-at-missouri-st-receives-nih-funding/2481759/daily0.7https://crstoday.com/news/skyline-therapeutics-gene-therapy-candidate-for-namd-receives-ind-clearance/2481758/daily0.7https://crstoday.com/news/vantage-acquires-ophthalmic-surgical-solutions/2481757/daily0.7https://crstoday.com/news/harrow-launches-vigamox-in-the-united-states/2481756/daily0.7https://crstoday.com/news/shamir-insight-launches-driver-intelligence-lens-technology/2481754/daily0.7https://crstoday.com/news/okyo-pharmas-ok-101-will-be-evaluated-to-treat-neuropathic-corneal-pain-in-study-at-tufts/2481753/daily0.7https://crstoday.com/news/helpmesee-and-usaid-partner-to-train-new-cataract-specialists-to-provide-surgical-care-for-indias-cataract-blind/2481752/daily0.7https://crstoday.com/news/glauconix-changes-name-to-humonix/2481751/daily0.7https://crstoday.com/news/versea-ophthalmics-will-distribute-celularitys-biovance-and-biovance-3l-ocular-products-in-the-united-states/2481750/daily0.7https://crstoday.com/news/asclepix-therapeutics-raises-10-million-to-advance-phase-12a-clinical-study-of-axt107/2481749/daily0.7https://crstoday.com/news/versea-ophthalmics-commences-phase-1-launch-of-novel-tear-based-point-of-care-t-poc-quantitative-testing-platform/2481745/daily0.7https://crstoday.com/news/fda-approves-xdemvy-first-treatment-for-demodex-blepharitis/2481743/daily0.7https://crstoday.com/news/study-identifies-how-diabetes-slows-healing-in-the-eye/2481742/daily0.7https://crstoday.com/news/fda-accepts-dorcs-orphan-drug-designation-application-for-trypan-blue-and-brilliant-blue-g/2481740/daily0.7https://crstoday.com/news/restoringvision-appoints-of-three-directors-to-its-leadership-team/2481739/daily0.7https://crstoday.com/news/bvi-expands-iol-capacity-with-new-facility-in-belgium/2481738/daily0.7https://crstoday.com/news/visiox-pharma-licenses-glaucoma-drug-omlonti-from-santen/2481736/daily0.7https://crstoday.com/news/harrow-acquires-santens-branded-ophthalmic-portfolio/2481735/daily0.7https://crstoday.com/news/harrow-acquires-us-and-canadian-commercial-rights-to-vevye-cyclosporine-ophthalmic-solution-01-from-novaliq/2481734/daily0.7https://crstoday.com/news/chromadex-nicotinamide-rrboside-nr-may-be-a-potential-therapeutic-strategy-for-glaucoma-patients/2481733/daily0.7https://crstoday.com/news/lars-ederleh-named-new-cso-at-schwind-eye-tech-solutions/2481731/daily0.7https://crstoday.com/news/caeregen-therapeutics-receives-14-million-phase-2-sbir-grant-from-nihnei-to-advance-development-of-regenerative-medicine-clinical-candidate-ctr-107-noregen-for-retinal-diseases/2481729/daily0.7https://crstoday.com/news/glaukos-enters-into-a-collaboration-and-marketing-agreement-with-radius-xr/2481728/daily0.7https://crstoday.com/news/smartlens-closes-61-million-series-a-financing-to-advance-milens/2481727/daily0.7https://crstoday.com/news/kapil-bharti-is-neis-new-scientific-director/2481726/daily0.7https://crstoday.com/news/study-low-dose-atropine-eye-drops-no-better-than-placebo-for-slowing-myopia-progression/2481725/daily0.7https://crstoday.com/news/new-study-shows-zepto-precision-pulse-capsulotomy-safeguards-endothelial-cells-as-effectively-as-manual-capsulorhexis/2481724/daily0.7https://crstoday.com/news/medical-consulting-group-and-corcoran-consulting-group-finalize-merger-agreement/2481723/daily0.7https://crstoday.com/news/dean-burns-named-president-and-ceo-of-ocumetics/2481722/daily0.7https://crstoday.com/news/astellas-enters-license-agreement-with-4d-molecular-therapeutics-4dmt-to-use-proprietary-intravitreal-r100-vector-for-rare-ophthalmic-targets/2481721/daily0.7https://crstoday.com/news/tenpoint-therapeutics-launches-with-goal-of-reversing-vision-loss-through-engineered-cell-based-therapeutics-and-in-vivo-reprogramming/2481720/daily0.7https://crstoday.com/news/nacuity-pharmaceuticals-advances-phase-12-trial-evaluating-npi-002-intravitreal-implant-for-the-delay-of-cataract-progression/2481719/daily0.7https://crstoday.com/news/iris-and-aeye-health-announce-partnership-to-provide-ai-screening-to-market/2481718/daily0.7https://crstoday.com/news/allotex-secures-funding-for-allogeneic-presbyopia-inlays/2481717/daily0.7https://crstoday.com/news/viridian-announces-positive-data-from-ongoing-phase-12-trial-evaluating-vrdn-001-in-patients-with-chronic-thyroid-eye-disease-ted/2481716/daily0.7https://crstoday.com/news/jay-s-duker-md-named-ceo-of-eyepoint-pharmaceuticals/2481715/daily0.7https://crstoday.com/news/kiora-pharmaceuticals-receives-12-million-in-research-tax-credits-to-advance-the-treatment-of-ophthalmic-disease/2481713/daily0.7https://crstoday.com/news/nicox-estimates-potential-annual-global-net-sales-for-ncx-470-of-over-300-million/2481712/daily0.7https://crstoday.com/news/spyglass-pharma-completes-90-million-series-c-financing-to-advance-novel-treatments-for-glaucoma-and-other-chronic-ophthalmic-diseases/2481711/daily0.7https://crstoday.com/news/rvl-launches-prescription-e-commerce-platform-elevate/2483714/daily0.7https://crstoday.com/news/heidelberg-engineering-names-hartmut-becker-head-of-global-sales/2481710/daily0.7https://crstoday.com/news/bausch-lomb-acquires-blink-eye-drops-from-jj-vision/2481709/daily0.7https://crstoday.com/news/elios-vision-announces-collaboration-with-the-international-glaucoma-surgical-registry/2481708/daily0.7https://crstoday.com/news/salvat-laboratories-initiates-a-pediatric-study-in-europe-with-svt-15473-for-the-treatment-of-inflammation-and-pain-following-ocular-surgery/2481707/daily0.7https://crstoday.com/news/iapb-world-sight-day-photo-competition-to-highlight-eye-health-in-the-workplace-as-2023-judges-announced/2483713/daily0.7https://crstoday.com/news/mount-sinai-launches-center-for-ophthalmic-artificial-intelligence-and-human-health/2481706/daily0.7https://crstoday.com/news/nicox-presents-ncx-470-phase-3-mont-blanc-adaptive-design-data-and-additional-subset-analysis-at-the-world-glaucoma-congress/2481705/daily0.7https://crstoday.com/news/new-analysis-of-mri-findings-shows-uplinza-reduced-the-formation-of-subclinical-spinal-cord-lesions-in-people-with-nmosd/2483712/daily0.7https://crstoday.com/news/bausch-lomb-will-acquire-xiidra/2481704/daily0.7https://crstoday.com/news/new-vision-program-will-test-the-sight-of-47500-rural-zambians/2483711/daily0.7https://crstoday.com/news/onesight-essilorluxottica-foundation-encourages-eye-doctors-to-adopt-a-local-school-and-help-more-kids-see-clearly/2481702/daily0.7https://crstoday.com/news/elios-vision-completes-enrollment-in-us-pivotal-trial-expands-us-pre-launch-team-and-continues-to-generate-commercial-uptake-in-europe/2481701/daily0.7https://crstoday.com/news/eyecare-partners-introduces-advanced-comprehensive-ophthalmology-fellowship-acof-for-ophthalmology-training/2483710/daily0.7https://crstoday.com/news/dopavision-provides-clinical-trial-update-and-announces-all-myopiax-1-trial-sites-are-active/2481699/daily0.7https://crstoday.com/news/ciliatech-presents-2-year-postoperative-results-on-new-cilio-scleral-surgical-approach-for-treating-glaucoma/2481698/daily0.7https://crstoday.com/news/srinivas-r-sadda-md-named-2023-2024-arvo-president-elect/2481697/daily0.7https://crstoday.com/news/myra-vision-raises-money-to-advance-calibreye-surgical-treatment-for-glaucoma-patients/2481694/daily0.7https://crstoday.com/news/ior-publishes-ophthalmic-office-based-surgery-safety-study/2481693/daily0.7https://crstoday.com/news/luminopia-raises-money-to-support-full-commercial-rollout-of-amblyopia-therapeutic/2481692/daily0.7https://crstoday.com/news/euclid-announces-abb-optical-group-as-licensed-manufacturer-and-distributor-of-euclid-ortho-k-lenses/2481691/daily0.7https://crstoday.com/news/the-international-agency-for-the-prevention-of-blindness-iapb-welcomes-over-300-international-delegates-to-singapore/2481690/daily0.7https://crstoday.com/news/bruder-healthcare-expands-dry-eye-portfolio-with-eye-care-distribution-of-allerfocus-percutaneous-allergy-test/2481689/daily0.7https://crstoday.com/news/cigna-expands-coverage-of-glaucoma-surgical-procedures-to-include-canaloplasty-and-goniotomy-trabeculotomy/2481686/daily0.7https://crstoday.com/news/fda-clearance-expands-the-label-of-eyenuks-eyeart-ai-system-for-the-detection-of-dr/2481685/daily0.7https://crstoday.com/news/fda-rejects-aldeyras-nda-for-rare-eye-cancer-drug-adx-2191/2481684/daily0.7https://crstoday.com/news/istar-medical-to-present-new-3-year-star-global-data-at-world-glaucoma-congress/2481683/daily0.7https://crstoday.com/news/bvi-launches-finevision-hp-trifocal-iol-in-japan/2481681/daily0.7https://crstoday.com/news/eversight-expands-eye-banking-services-to-arizona/2483709/daily0.7https://crstoday.com/news/new-analysis-from-n-momentum-clinical-trial-of-uplinza-demonstrate-process-that-could-improve-clinical-care-process-for-nmosd/2481680/daily0.7https://crstoday.com/news/new-data-from-tepezza-clinical-trials-and-real-world-analyses-shed-light-on-link-between-thyroid-autoimmunity-and-hearing-risks/2483708/daily0.7https://crstoday.com/news/study-lab-grown-mini-corneas-mimic-developing-human-corneas/2481678/daily0.7https://crstoday.com/news/marinomed-biotech-to-launch-carragelose-eye-drops-in-europe-in-2024/2481677/daily0.7https://crstoday.com/news/aldeyra-therapeutics-achieves-statistical-significance-for-primary-and-secondary-endpoints-in-phase-3-trial-of-reproxalap-in-allergic-conjunctivitis-1/2481676/daily0.7https://crstoday.com/news/zeiss-unveils-disposable-zeiss-warm-eye-masks/2481674/daily0.7https://crstoday.com/news/beacon-therapeutics-launches-with-goal-of-developing-gene-therapies-for-retinal-diseases/2481673/daily0.7https://crstoday.com/news/alcon-announces-results-of-the-alcon-eye-on-cataract-survey/2481672/daily0.7https://crstoday.com/news/lighthouse-guild-awards-college-scholarships-of-10000-each-to-15-students-who-are-blind/2483707/daily0.7https://crstoday.com/news/senju-pharmaceutical-and-novaliq-enter-into-license-agreement-for-nov03-for-the-treatment-of-dry-eye-disease-in-japan/2481671/daily0.7https://crstoday.com/news/fda-clears-corneat-everpatch-worlds-first-non-degradable-synthetic-tissue-substitute-for-ophthalmic-surgery/2481668/daily0.7https://crstoday.com/news/bausch-lomb-launches-preservision-areds-2-formula-soft-gels-plus-coq10-in-the-united-states/2481667/daily0.7https://crstoday.com/news/new-nerve-insights-could-someday-help-heal-certain-types-of-blindness-and-paralysis/2481666/daily0.7https://crstoday.com/news/mediprint-ophthalmics-announces-results-from-its-sight-2-phase-2b-group-1-clinical-study/2481665/daily0.7https://crstoday.com/news/novaliq-announces-fda-approval-of-vevye-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/2481664/daily0.7https://crstoday.com/news/reduction-of-eyedrop-volume-for-topical-ophthalmic-medications-with-the-nanodropper-bottle-adaptor/2481663/daily0.7https://crstoday.com/news/bausch-lomb-announces-new-scientific-data-and-analyses-featuring-consumer-vision-care-and-pharmaceuticals-will-be-presented-during-optometrys-meeting/2481662/daily0.7https://crstoday.com/news/new-data-from-phase-3-n-momentum-trial-of-horizons-uplinza-published/2481660/daily0.7https://crstoday.com/news/cellusion-raises-21-million-to-advance-ips-cell-derived-corneal-endothelial-cell-substitute/2481659/daily0.7https://crstoday.com/news/prevent-blindness-launches-multiple-efforts-to-provide-education-and-resources-on-the-effects-of-vision-loss-and-blindness-on-mental-health/2481658/daily0.7https://crstoday.com/news/cofi-raises-35-million-to-support-expansion-of-its-multi-party-payment-platform-for-premium-elective-ophthalmic-surgeries/2481656/daily0.7https://crstoday.com/news/apples-provides-new-vision-health-features-on-ios-17-ipados-17-and-watchos-10/2481655/daily0.7https://crstoday.com/news/sightglass-vision-presents-new-myopia-control-science-and-clinical-insights-at-2023-bcla-conference/2481654/daily0.7https://crstoday.com/news/aos-launches-remote-visual-acuity-system-platform/2481652/daily0.7https://crstoday.com/news/yuyu-pharma-announces-topline-results-from-the-icecap-phase-12-trial-of-yp-p10-in-dry-eye-disease/2481651/daily0.7https://crstoday.com/news/glaukos-achieves-pipeline-milestone-with-enrollment-completion-in-phase-3-confirmatory-trial-for-epioxa-epi-on/2481650/daily0.7https://crstoday.com/news/gamesquare-partners-with-vivior-to-help-gamers-build-healthy-screen-habits/2481646/daily0.7https://crstoday.com/news/optos-announces-new-ultra-widefield-color-image-modality-providing-additional-retinal-visualization/2481645/daily0.7https://crstoday.com/news/bausch-lomb-announces-leadership-changes/2481644/daily0.7https://crstoday.com/news/biotissues-sharing-miracles-partners-with-dakota-lions-sight-health-to-expand-birth-tissue-donation/2481642/daily0.7https://crstoday.com/news/thea-pharma-launches-preservative-freedom-coalition-to-advocate-for-preservative-free-eye-care/2481639/daily0.7https://crstoday.com/news/ai-used-to-advance-drug-delivery-system-for-glaucoma-and-other-chronic-diseases/2481636/daily0.7https://crstoday.com/news/nei-explores-potential-impacts-of-climate-change-on-eye-health/2481635/daily0.7https://crstoday.com/news/norlase-secures-11m-in-new-funding-following-regulatory-clearance-of-echo-pattern-laser/2481634/daily0.7https://crstoday.com/news/sight-sciences-two-year-study-results-show-sustained-reductions-in-iop-and-glaucoma-medication-use-in-mild-moderate-poag-patients-treated-with-omni/2481630/daily0.7https://crstoday.com/news/dr-louis-r-pasquale-winner-of-the-glaucoma-foundations-2023-robert-ritch-award/2481629/daily0.7https://crstoday.com/news/bausch-lomb-and-novaliq-announce-fda-approval-of-miebotm-perfluorohexyloctane-ophthalmic-solution-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/2481625/daily0.7https://crstoday.com/news/alimera-acquires-us-commercial-rights-to-yutiq/2481624/daily0.7https://crstoday.com/news/novel-imaging-technology-reveals-role-of-immune-cells-in-early-diabetic-cataract-development-1/2481623/daily0.7https://crstoday.com/news/international-sports-vision-association-launches-ask-a-sports-vision-expert-feature/2481622/daily0.7https://crstoday.com/news/ray-therapeutics-closes-oversubscribed-100m-series-a-financing-to-advance-optogenetic-gene-therapies/2481621/daily0.7https://crstoday.com/news/euclid-and-visionary-optics-announce-interactive-specialty-lens-forums-in-cities-across-the-us/2481620/daily0.7https://crstoday.com/news/invirsa-completes-enrollment-of-phase-12a-dry-eye-study/2481619/daily0.7https://crstoday.com/news/oculus-incorporates-new-subsidiary-in-india/2481614/daily0.7https://crstoday.com/news/lumibird-medical-renames-its-polish-subsidiary-to-lumibird-medical-polska/2481613/daily0.7https://crstoday.com/news/new-museum-of-the-eye-exhibit-explores-the-eye-as-a-cultural-symbol-from-ancient-to-modern-times/2481612/daily0.7https://crstoday.com/news/dry-eye-foundation-calls-on-retailers-to-address-rampant-sales-of-potentially-unsafe-eye-drops/2481611/daily0.7https://crstoday.com/news/delta-gamma-foundation-awards-restoringvision-with-grant-to-serve-people-in-need-of-vision-services-and-eyeglasses-in-the-us/2481609/daily0.7https://crstoday.com/news/new-acuvue-campaign-encourages-gen-z-to-take-a-social-media-break/2481606/daily0.7https://crstoday.com/news/trefoils-investigational-candidate-tthx1114-improves-rate-of-visual-recovery-after-descemet-stripping-only-dso-in-phase-2-storm-data-presented-at-ascrs/2481605/daily0.7https://crstoday.com/news/salvat-laboratories-presents-phase-3-clinical-trials-results-of-clobetasol-nanoemulsion-for-treating-inflammation-and-pain-after-ocular-surgery/2481604/daily0.7https://crstoday.com/news/eyenovia-receives-fda-approval-of-mydcombi-the-first-ophthalmic-spray-for-mydriasis/2481603/daily0.7https://crstoday.com/news/formosa-and-aimmax-announce-the-nda-submission-to-the-fda-for-app13007-for-postoperative-inflammation-and-pain-following-ocular-surgery/2481602/daily0.7https://crstoday.com/news/cassini-launches-cassini-connect-digital-cataract-surgery-suite/2481601/daily0.7https://crstoday.com/news/sight-sciences-announces-12-month-results-from-the-first-migs-comparative-analysis-of-real-world-data-rwd-from-the-iris-registry/2481600/daily0.7https://crstoday.com/news/glaukos-announces-fda-acceptance-of-nda-submission-for-idose-tr/2481599/daily0.7https://crstoday.com/news/atia-vision-announces-presentation-of-first-in-human-results-with-their-novel-intraocular-lens-at-ascrs/2481598/daily0.7https://crstoday.com/news/norlase-receives-fda-510k-clearance-and-ce-mark-approval-for-echo-green-pattern-laser/2481597/daily0.7https://crstoday.com/news/harrow-to-launch-fda-approved-iheezo-at-the-2023-ascrs/2481596/daily0.7https://crstoday.com/news/visus-therapeutics-presents-topline-clinical-data-from-phase-3-pivotal-brio-i-trial-of-brimochol-pf-for-the-treatment-of-presbyopia-at-eyecelerator-at-ascrs-2023/2481595/daily0.7https://crstoday.com/news/johnson-johnson-vision-to-present-and-support-43-company-sponsored-and-investigator-led-studies-at-ascrs/2481593/daily0.7https://crstoday.com/news/fda-clears-centricity-visions-zeptolink-iol-positioning-system/2481592/daily0.7https://crstoday.com/news/alcon-expands-plastic-bank-partnership-in-2023-to-further-support-sustainability-efforts/2481591/daily0.7https://crstoday.com/news/sight-sciences-glaucoma-and-dry-eye-technologies-to-be-featured-in-multiple-clinical-presentations-at-the-2023-ascrs/2481590/daily0.7https://crstoday.com/news/zeiss-to-present-new-surgical-workflow-innovations-at-ascrs/2481589/daily0.7https://crstoday.com/news/alcon-announces-its-largest-scientific-presence-at-ascrs-2023-and-expands-image-guided-connectivity/2481588/daily0.7https://crstoday.com/news/harrow-launches-recently-acquired-products-ilevro-nevanec-and-maxidex-in-the-us/2481587/daily0.7https://crstoday.com/news/aurion-biotech-to-present-clinical-trial-results-at-the-2023-ascrs-annual-meeting/2481586/daily0.7https://crstoday.com/news/julie-schornack-od-named-first-female-president-of-marshall-b-ketchum-university/2481585/daily0.7https://crstoday.com/news/alcon-names-daniel-m-miller-md-phd-senior-scientific-advisor-to-alcons-rd-team-pdf/2481584/daily0.7https://crstoday.com/news/vialase-to-present-clinical-data-at-the-2023-ascrs-annual-meeting/2481582/daily0.7https://crstoday.com/news/bvi-completes-enrollment-of-finevision-hp-ide-clinical-study/2481581/daily0.7https://crstoday.com/news/vmg-health-acquires-healthcare-consulting-firm-bsm-consulting/2481579/daily0.7https://crstoday.com/news/glaukos-featured-in-numerous-scientific-abstracts-at-the-2023-ascrs-meeting/2481578/daily0.7https://crstoday.com/news/ocumension-therapeutics-receives-priority-review-status-for-zerviate-new-drug-application-in-china/2481575/daily0.7https://crstoday.com/news/johnson-johnson-vision-receives-fda-clearance-for-its-elita-femtosecond-laser/2481573/daily0.7https://crstoday.com/news/essilorluxottica-unveils-4-year-clinical-trial-results-of-its-essilor-stellest-lens-at-arvo-at/2481572/daily0.7https://crstoday.com/news/medical-consulting-group-and-corcoran-consulting-group-announce-merger/2481571/daily0.7https://crstoday.com/news/lumibird-launches-tango-neo-and-ultraq-reflex-neo-lasers/2481570/daily0.7https://crstoday.com/news/registration-now-open-for-neuro-optometric-rehabiliation-association-2023-conference/2481568/daily0.7https://crstoday.com/news/new-data-on-two-nicoxs-assets-ncx-470-and-ncx-1728-presented-at-arvo-2023/2481567/daily0.7https://crstoday.com/news/bausch-lomb-announces-the-presentation-of-new-scientific-data-on-products-and-pipeline-programs-at-ascrs/2481566/daily0.7https://crstoday.com/news/advances-in-holographic-oct-receive-heidelberg-engineering-xtreme-research-award-2023/2481565/daily0.7https://crstoday.com/news/esight-names-new-senior-leadership/2481562/daily0.7https://crstoday.com/news/zeiss-receives-fda-approval-of-the-ct-lucia-621p-monofocal-iol/2481561/daily0.7https://crstoday.com/news/ciliatech-raises-money-to-advance-development-of-disruptive-glaucoma-implant/2481560/daily0.7https://crstoday.com/news/gensight-biologics-withdraws-its-ema-application-for-lumevoq/2481559/daily0.7https://crstoday.com/news/lenstar-myopia-now-includes-new-ammc-framework-by-prof-dr-hakan-kaymak/2481558/daily0.7https://crstoday.com/news/stoke-therapeutics-receives-authorization-to-initiate-a-phase-12-study-of-stk-002-for-autosomal-dominant-optic-atrophy-adoa-in-the-united-kingdom/2483706/daily0.7https://crstoday.com/news/new-trefoil-therapeutics-data-presented-at-arvo-demonstrate-that-tthx1114-controls-edema-in-at-risk-patients-undergoing-cataract-surgery/2481556/daily0.7https://crstoday.com/news/tarsus-appoints-jeff-farrow-as-chief-financial-officer-and-chief-strategy-officer/2483705/daily0.7https://crstoday.com/news/bausch-lomb-announces-us-launch-of-stablevisc-cohesive-ophthalmic-viscosurgical-device-and-totalvisc-viscoelastic-system/2481555/daily0.7https://crstoday.com/news/johnson-johnson-vision-showcases-30-new-sets-of-scientific-data-on-myopia-refractive-technologies-iols-and-more-at-arvo/2481554/daily0.7https://crstoday.com/news/apellis-presents-phase-3-functional-analyses-of-syfovre-for-geographic-atrophy/2481553/daily0.7https://crstoday.com/news/sightglass-vision-research-reinforces-myopia-control-efficacy-and-safety-of-diffusion-optics-technology-spectacle-lenses/2481552/daily0.7https://crstoday.com/news/coopervision-study-links-individual-osdi-responses-to-clinical-measures-spotlighting-possible-treatment/2481551/daily0.7https://crstoday.com/news/retinai-joins-forces-with-boehringer-ingelheim-to-advance-novel-treatments-for-patients-with-ga-using-artificial-intelligence/2481550/daily0.7https://crstoday.com/news/coopervision-seeks-proposals-for-2023-science-and-technology-awards/2481549/daily0.7https://crstoday.com/news/mina-sooch-out-as-ceo-of-ocuphire-pharma-rick-rodgers-to-serve-as-interim-ceo/2481548/daily0.7https://crstoday.com/news/one-million-patients-measured-on-the-neurolens-measurement-device/2481546/daily0.7https://crstoday.com/news/bausch-lomb-to-present-new-data-on-products-and-pipeline-programs-at-arvo/2481545/daily0.7https://crstoday.com/news/azura-ophthalmics-to-present-new-data-on-azr-md-001-in-meibomian-gland-dysfunction-at-ascrs-and-arvo/2481544/daily0.7https://crstoday.com/news/visus-therapeutics-announces-positive-topline-clinical-data-from-phase-3-trial-of-brimochol-pf-for-the-treatment-of-presbyopia/2481543/daily0.7https://crstoday.com/news/iridex-launches-next-gen-pascal-laser-with-micropulse-in-us/2481542/daily0.7https://crstoday.com/news/visus-therapeutics-announces-new-scientific-data-to-be-presented-at-arvo-2023/2481541/daily0.7https://crstoday.com/news/bausch-lomb-reports-more-than-65-million-units-of-contact-lens-eye-care-and-lens-care-materials-recycled-through-one-by-one-and-biotrue-eye-care-recycling-programs/2481540/daily0.7https://crstoday.com/news/core-demonstrates-advanced-3d-printing-for-ocular-research-at-arvo-2023/2481539/daily0.7https://crstoday.com/news/vialase-announces-publication-of-24-month-safety-data-from-first-in-human-study-of-femtosecond-laser-image-guided-high-precision-trabeculotomy-flight/2481538/daily0.7https://crstoday.com/news/trefoil-therapeutics-announces-tthx1114-data-presentations-at-the-arvo-2023/2481536/daily0.7https://crstoday.com/news/nidek-launches-the-nt-11e-non-contact-tonometer/2481535/daily0.7https://crstoday.com/news/ocumension-therapeutics-submits-a-new-drug-application-for-zerviate-in-china/2481533/daily0.7https://crstoday.com/news/haag-streit-launches-new-eyesuite-software/2481532/daily0.7https://crstoday.com/news/ocutrx-technologies-acquires-circuit-board-manufacturing-company-spectrum-advanced-manufacturing-technologies/2481531/daily0.7https://crstoday.com/news/nova-eye-medical-announces-us-market-clearance-of-the-itrack-advance-canaloplasty-device/2481530/daily0.7https://crstoday.com/news/bausch-lomb-and-heidelberg-engineering-introduce-seeluma-fully-digital-surgical-visualization-platform/2481528/daily0.7https://crstoday.com/news/kala-pharmaceuticals-receives-fda-fast-track-designation-for-kpi-012-a-human-msc-s-therapy-for-persistent-corneal-epithelial-defect/2481526/daily0.7